or
forgot password

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure


N/A
N/A
21 Years
Open (Enrolling)
Both
Stem Cell Transplantation, Blood and Marrow Transplant (BMT)

Thank you

Trial Information

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure


Inclusion Criteria:

- Hematopoietic stem cell transplantation (HSCT) for any indication.

- Patients will range from age 0 to age 21. There is no gender restriction. We expect
the male to female ratio to end up being about 50/50

- Ability to understand and the willingness to sign a written informed consent
document.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Rajni Agarwal-Hashmi

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

SU-09222008-1301

NCT ID:

NCT01135355

Start Date:

July 2008

Completion Date:

July 2011

Related Keywords:

  • Stem Cell Transplantation
  • Blood and Marrow Transplant (BMT)
  • Respiratory Insufficiency

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317